Please login to the form below
Primaxin
This page shows the latest Primaxin news and features for those working in and with pharma, biotech and healthcare.
FDA accepts priority review for Merck’s antibiotic combo Recarbrio
The regimen combines Merck’s imipenem/cilastatin duo – sold as Primaxin as a broad-spectrum antibiotic – with a new beta lactamase inhibitor called relebactam that is designed to restore the susceptibility
Latest news
-
Merck preps regulatory filings for much-needed antibiotic combo
The regimen combines Merck’s own Primaxin with new beta lactamase inhibitor relebactam. ... The regimen combines Merck’s imipenem/cilastatin duo - sold as Primaxin as a broad-spectrum antibiotic for decades - with a new beta lactamase inhibitor
-
Merck starts pivotal trials of new antibiotic combination
The drug is designed to inhibit a key resistance mechanism that inhibits the effectiveness of beta lactam antibiotics, and will be studied in phase III in combination with Merck's Primaxin
-
News in brief, January 16, 2007
A Pharmacor report, Emerging Antibacterial Agents, found that J&Jís Levaquin, SAís Tavanic, DSís Cravit, Merckís Primaxin, Abbottís.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Havas Life Medicom
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
